Five Steps to advance COVID-19 vaccine equity
Step #3
As part of the efforts to promote our Five Steps to urgently advance COVID-19 vaccine equity and help bring the pandemic under control, we have published a new video and blog on Step #3: call out trade barriers to be eliminated. These new resources focus on addressing and eliminating unnecessary supply chain barriers and export restrictions to ensure timely access to COVID-19 vaccines for all
Five Steps to urgently advance COVID-19 vaccine equity
Step 3: Call out trade barriers to be eliminated
To put an end to the pandemic, industry was tasked with manufacturing and supplying billions of COVID-19 vaccines, starting from zero. This monumental task is on its way to being achieved, however, trade restrictions, amongst other hurdles, are holding up both upstream and downstream supply, presenting a significant challenge to achieve vaccine equity. Read the blog here.
Step 2: Continue to optimize production
From zero to billions: manufacturing COVID-19 vaccines is a colossal challenge. Boosting production is the key. With nearly 300 manufacturing agreements with trusted partners to scale up production, the industry is on target to produce 11 billion vaccine doses by the end of 2021, but rapid action is still needed to tackle manufacturing bottlenecks. Watch the video here.